Business Standard

India Coronavirus Dispatch: UP, Bihar worst in Covid reporting, finds study

Daily positivity rate at 11.61%, private hospitals struggle to access remdesivir, and how much should you worry about air conditioning-news on how India is dealing with the pandemic

Coronavirus, doctors, MEDICAL, health, workers, medics, covid
Premium

Friday saw India conduct 420,000 tests for Covid-19, the highest yet. It also saw the highest number of new cases being detected in a day — 48,894

Sarah Farooqui New Delhi
Interview

Itolizumab a game-changer in trying to reduce mortality, not for Covid: Biocon said it was launching itolizumab, for emergency use to treat cytokine release syndrome in moderate to severe cases of acute respiratory distress syndrome due to Covid-19. Itolizumab has been used to treat psoriasis. The drug regulates the immune response in order to prevent a cytokine storm -- when excessive or uncontrolled levels of cytokines are released, activating more immune cells. This results in hyperinflammation, and causes sepsis or organ failure, which can all be fatal. Read this interview with Hemant Thacker, the first Mumbai

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 26 2020 | 3:19 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com